STAT3 pathway in cancers: Past, present, and future

HQ Wang, QW Man, FY Huo, X Gao, H Lin, SR Li… - MedComm, 2022 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3), a member of the STAT family,
discovered in the cytoplasm of almost all types of mammalian cells, plays a significant role in …

[HTML][HTML] Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease

L Duan, S Cheng, L Li, Y Liu, D Wang… - Frontiers in …, 2021 - frontiersin.org
Inflammatory bowel disease (IBD) represents chronic recurrent intestinal inflammation
resulting from various factors. Crohn's disease (CD) and ulcerative colitis (UC) have been …

[HTML][HTML] Anti-inflammatory natural products modulate interleukins and their related signaling markers in inflammatory bowel disease: A systematic review

GR Gandhi, T Mohana, K Athesh, VE Hillary… - Journal of …, 2023 - Elsevier
This review aims to identify in vivo studies investigating the potential of plant substances and
their natural molecules in managing inflammatory bowel disease (IBD). Specifically, the …

[HTML][HTML] Fat of the gut: epithelial phospholipids in inflammatory bowel diseases

LV Boldyreva, MV Morozova, SS Saydakova… - International journal of …, 2021 - mdpi.com
Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting
from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant …

Drug delivery to the inflamed intestinal mucosa–targeting technologies and human cell culture models for better therapies of IBD

O Hartwig, MAS Boushehri, KS Shalaby… - Advanced Drug Delivery …, 2021 - Elsevier
Current treatment strategies for inflammatory bowel disease (IBD) seek to alleviate the
undesirable symptoms of the disorder. Despite the higher specificity of newer generation …

Oral colon-targeted responsive alginate/hyaluronic acid-based hydrogel propels the application of infliximab in colitis

M Huai, M Pei, J Pan, Y Zhu, Y Chen, P Du… - International Journal of …, 2023 - Elsevier
Currently, commercialized infliximab (IFX) has rapidly propelled the clinical treatment of IBD,
however, its inherent attributes, such as off-target effects and rapid metabolism, severely …

[HTML][HTML] The function of natural polysaccharides in the treatment of ulcerative colitis

Y Guo, Y Li, Q Cao, L Ye, J Wang, M Guo - Frontiers in Pharmacology, 2022 - frontiersin.org
Ulcerative colitis (UC) is an inflammatory bowel disease that is persistent and nonspecific.
There are several medications available for the treatment of UC. However, conventional UC …

[HTML][HTML] Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: clinical evidence and potential mechanisms

J Chen, B Shen, Z Jiang - Frontiers in pharmacology, 2022 - frontiersin.org
Ulcerative colitis (UC), characterized by syndromes including abdominal pain, bloody stool,
diarrhea, weight loss, and repeated relapse, is a non-specific inflammatory intestinal …

Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease

M Purohit, G Gupta, O Afzal, ASA Altamimi… - Chemico-biological …, 2023 - Elsevier
A key signaling channel for the signal transduction of several crucial cytokines implicated in
sepsis is the JAK/STAT system. Once cytokines attach to the proper receptors, JAK kinases …

Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C

V Mishra, A Bose, S Kiran, S Banerjee… - Journal of Experimental …, 2021 - rupress.org
Activating mutations in receptor guanylyl cyclase C (GC-C), the target of gastrointestinal
peptide hormones guanylin and uroguanylin, and bacterial heat-stable enterotoxins cause …